P&F Program

磷

• 批准号: 10016278
• 负责人: TOM A ELASY
• 金额: $ 9.62万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10016278
• 关键词: Applications Grants; Award; Behavior Therapy; Data; Diabetes Mellitus; Doctor of Medicine; Doctor of Philosophy; Eligibility Determination; Ensure; Expenditure; Faculty; Feasibility Studies; Funding; Funding Mechanisms; Grant; Guidelines; K-Series Research Career Programs; Lead; Letters; Measurement; Peer Review Grants; Pilot Projects; Research; Research Personnel; Research Project Grants; Research Support; Secure; Services; Structure; Technology; Testing; Time; Translational Research; Translations; United States National Institutes of Health; Update; Writing; base; design; instructor; member; programs; web site

This P&F program has been highly successful over the first five years of funding of this CDTR. Eight investigators have been funded at $30,000/year for two years (total of $60,000 per investigator). In general, year one of funding has come from the CDTR while year two has come from a combination of philanthropy or shared expenditures with Vanderbilt's CTSA (see letter of support from Gordon Bernard, M.D., director of Vanderbilt's CTSA). Four investigators have already received either a K award or a DP3 award and a fifth awardee has secured a RO1 (two P&F recipients have pending K applications at the time of this writing – the results of which will be updated on our website (https://labnodes.vanderbilt.edu/cdtr). Our R01 recipient (Chandra Osborn, Ph.D.) who received a K award will lead a new core (Behavioral Intervention Technologies and Services Core) that reflects both her research focus as well as research base demands. Translation core investigators support both the design (structured statistical and measurement support pre-submission), implementation and analysis of the P&F grants. Vanderbilt CDTR proposes continuation of support for Pilot and Feasibility (P&F) funding for type II translation research in diabetes through it's Administrative Core. These funds are used for: 1) new investigators; 2) established investigators from other fields who bring their research expertise to diabetes; or 3) investigators in diabetes research who wish to test a new idea. This funding mechanism provides support that will allow an investigator the opportunity to develop the pilot data that will serve as the basis for obtaining independent research support through conventional external, peer-reviewed granting mechanisms. Two P&F studies in any one year (one new and one continuation) are funded and the funding is not intended for large undertakings by established investigators for which it would be appropriate to submit separate research grant applications nor to support or supplement ongoing research. Currently applicants must be a member of the VUMC or Meharry faculty (Instructor or above) to submit a P&F proposal, and they must meet the NIH Eligibility Guidelines for P&F support.

这个P&F计划在这个CDTR的前五年资助中非常成功。八 调查员的经费为每年30 000美元，为期两年（每名调查员共计60 000美元）。总的来说， 第一年的资金来自CDTR，而第二年则来自慈善事业或 与范德比尔特的CTSA共享支出（见戈登·伯纳德医学博士的支持信，主任 范德比尔特的CTSA）。四名调查员已经获得K奖或DP 3奖，第五名调查员已经获得K奖或DP 3奖。 获奖者已经获得了RO 1（在撰写本文时，两名P&F获奖者有未决的K申请- 结果将在我们的网站上更新（https：//labnodes.vanderbilt.edu/cdtr）。我们的R 01接收者 （钱德拉奥斯本博士）他将领导一个新的核心（行为干预技术 和服务核心），既反映了她的研究重点，以及研究基地的需求。翻译核心 研究者支持设计（结构化统计和测量支持预提交）， 执行和分析P&F赠款。 范德比尔特CDTR建议继续支持II类翻译的试点和可行性（P&F）资金 糖尿病研究通过它的行政核心。这些资金用于：1）新的调查人员; 2） 来自其他领域的研究人员，他们将自己的研究专长带到糖尿病领域;或3） 糖尿病研究者希望测试一个新的想法。这一供资机制提供的支持将使 调查人员有机会开发试点数据，作为获得独立的基础， 通过传统的外部、同行评审的资助机制提供研究支持。任何两项P&F研究 一年（一个新的和一个继续）的资金，资金不打算用于大型企业， 已确定的研究人员，对于这些研究人员来说，提交单独的研究补助金申请是适当的， 支持或补充正在进行的研究。目前申请人必须是VUMC或Meharry的成员 教师（讲师或以上）提交P&F提案，他们必须符合NIH资格指南， P&F支持。